Decoding Gilead Sciences's Options Activity: What's the Big Picture?
Decoding Gilead Sciences's Options Activity: What's the Big Picture?
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Gilead Sciences's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Gilead Sciences's whale trades within a strike price range from $60.0 to $79.0 in the last 30 days. Financial giants have made a conspicuous bearish move on Gilead Sciences. Our analysis of options history for Gilead Sciences (NASDAQ:GILD) revealed 10 unusual trades.
金融巨头在吉利德科学上进行了明显的看淡操作。我们对吉利德科学（纳斯达克：GILD）的期权历史进行分析，发现了10笔异常交易。
Delving into the details, we found 20% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $310,182, and 2 were calls, valued at $112,717.
深入了解细节后，我们发现20%的交易员看好，而50%的交易员显示看淡倾向。我们发现所有交易中，有8笔看跌期权交易，价值为310,182美元；而有2笔看涨期权交易，价值为112,717美元。
Expected Price Movements
预期价格波动
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $79.0 for Gilead Sciences, spanning the last three months.
在评估交易量和持仓量后，显然主要的市场推动者将吉利德科学的价格区间集中在60.0美元到79.0美元之间，跨越过去三个月。
Insights into Volume & Open Interest
成交量和持仓量分析
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Gilead Sciences's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Gilead Sciences's whale trades within a strike price range from $60.0 to $79.0 in the last 30 days.
在交易期权时，查看成交量和持仓量是一个强有力的举措。这些数据可以帮助您跟踪吉利德科学在特定行权价的期权的流动性和兴趣。下面，我们可以观察过去30天内，吉利德科学所有鲸鱼交易的看涨期权和看跌期权的成交量和持仓量的演变，行权价范围为60.0美元到79.0美元。
Gilead Sciences Call and Put Volume: 30-Day Overview
Gilead Sciences 看涨和看跌期权成交量：30 天概览
Noteworthy Options Activity:
值得注意的期权活动：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILD | CALL | TRADE | NEUTRAL | 09/20/24 | $0.73 | $0.65 | $0.69 | $79.00 | $69.0K | 86 | 1.0K |
| GILD | PUT | SWEEP | BEARISH | 01/16/26 | $5.8 | $4.8 | $5.72 | $70.00 | $59.6K | 1.2K | 500 |
| GILD | PUT | SWEEP | BEARISH | 01/16/26 | $5.8 | $5.6 | $5.73 | $70.00 | $44.7K | 1.2K | 370 |
| GILD | CALL | SWEEP | BULLISH | 01/17/25 | $17.5 | $17.4 | $17.46 | $60.00 | $43.7K | 889 | 25 |
| GILD | PUT | SWEEP | NEUTRAL | 01/16/26 | $6.0 | $5.65 | $5.75 | $70.00 | $40.2K | 1.2K | 640 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILD | 看涨 | 交易 | 中立 | 09/20/24 | 0.73美元 | $0.65 | $0.69 | 79.00美元 | $69.0K | 86 | 1.0K |
| GILD | 看跌 | SWEEP | 看淡 | 01/16/26 | $5.8 | $4.8 | 70.00美元 | $59.6K | 1.2K | 500 | |
| GILD | 看跌 | SWEEP | 看淡 | 01/16/26 | $5.8 | $5.6 | $5.73 | 70.00美元 | $44.7K | 1.2K | 370 |
| GILD | 看涨 | SWEEP | 看好 | 01/17/25 | $17.5 | $17.4 | $60.00 | $43.7千美元 | 889 | 25 | |
| GILD | 看跌 | SWEEP | 中立 | 01/16/26 | $6.0 | $5.65 | $5.75 | 70.00美元 | $40.2K | 1.2K | 640 |
About Gilead Sciences
关于吉利德科学
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
吉利德科学开发和营销治疗危及生命的传染病，其核心组合主要关注HIV和乙型和C型肝炎。吉利德收购Pharmasset带来了对乙型肝炎药物Sovaldi的所有权，该药物也是较新的联合方案的一部分，仍然是标准治疗。吉利德还通过收购在肿瘤学市场上扩大了其存在，由CAR-t细胞疗法Yescarta/Tecartus（来自Kite）和乳腺和膀胱癌疗法Trodelvy（来自Immunomedics）领导。
In light of the recent options history for Gilead Sciences, it's now appropriate to focus on the company itself. We aim to explore its current performance.
考虑到吉利德科学最近的期权历史，现在应该关注该公司的表现。我们旨在探索其当前的业绩。
Gilead Sciences's Current Market Status
吉利德科学的当前市场状况
- Currently trading with a volume of 1,387,168, the GILD's price is down by -0.05%, now at $76.92.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 70 days.
- RSI读数表明该股票目前处于中立状态，处于超买和超卖之间。
- 预计在70天内发布收益。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Gilead Sciences options trades with real-time alerts from Benzinga Pro.
期权交易存在较高的风险和潜在回报。精明的交易者通过不断学习、调整策略、监控多种因子并密切关注市场动态来管理这些风险。随时通过Benzinga Pro获得有关吉利德科学期权交易的实时提醒，以保持了解最新情况。